Literature DB >> 32725588

Improvement of anti-Müllerian hormone and oxidative stress through regular exercise in Chinese women with polycystic ovary syndrome.

Xia Wu1, Heng Wu2, Wenjiang Sun3, Chen Wang4.   

Abstract

PURPOSE: Structured exercise is shown to be one of the most effective lifestyle interventions for women with polycystic ovary syndrome (PCOS). Anti-Müllerian hormone (AMH) has been proposed as a marker of ovarian dysfunction, and oxidative stress plays an important role in the development of PCOS. We sought to investigate whether there was any effect of aerobic exercise on AMH levels and oxidative stress in Chinese PCOS women.
METHODS: Thirty-eight PCOS women were enrolled and divided into two groups. The exercise group carried out a 12-week exercise program, while the control group maintained their normal lifestyle. All women underwent blood tests and cardiopulmonary exercise tests (CPETs) at enrollment and at 12-week follow-up.
RESULTS: At baseline, there was no statistically significant difference between the two groups in clinical characteristics, AMH, oxidative biomarkers, and CPET parameters. After 12 weeks, body mass index (BMI) and cardiovascular fitness indexes of the exercise group were improved. We also found a decrease in AMH (P = 0.021) and malondialdehyde (MDA) (P = 0.002) and an increase in superoxide dismutase (SOD) (P = 0.009) and total antioxidant capacity (TAC) (P = 0.012) in the exercise group, while there was no change in the control group. Moreover, the change of AMH was positively associated with the change of MDA (r = 0.23, P = 0.003) in the exercise group.
CONCLUSIONS: Our findings demonstrated that 12 weeks of aerobic exercise produced beneficial effects on BMI, cardiovascular fitness, AMH, and oxidative stress in PCOS women. Favorable modification of oxidative stress might thus be an effective method for improvement of AMH in these women, which deserves further exploration in the future.

Entities:  

Keywords:  Aerobic exercise; Anti-Müllerian hormone; Oxidative stress; Polycystic ovary syndrome

Mesh:

Substances:

Year:  2020        PMID: 32725588     DOI: 10.1007/s42000-020-00233-7

Source DB:  PubMed          Journal:  Hormones (Athens)        ISSN: 1109-3099            Impact factor:   2.885


  33 in total

1.  Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome.

Authors:  Sezai Sahmay; Nil Atakul; Mahmut Oncul; Abdullah Tuten; Begum Aydogan; Hakan Seyisoglu
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2013-06-24       Impact factor: 2.435

Review 2.  Criteria, prevalence, and phenotypes of polycystic ovary syndrome.

Authors:  Daria Lizneva; Larisa Suturina; Walidah Walker; Soumia Brakta; Larisa Gavrilova-Jordan; Ricardo Azziz
Journal:  Fertil Steril       Date:  2016-05-24       Impact factor: 7.329

Review 3.  Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.

Authors:  Héctor F Escobar-Morreale
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

4.  Antimüllerian hormone and polycystic ovary syndrome.

Authors:  Yi-Hui Lin; Wan-Chun Chiu; Chien-Hua Wu; Chii-Ruey Tzeng; Chun-Sen Hsu; Ming-I Hsu
Journal:  Fertil Steril       Date:  2011-05-05       Impact factor: 7.329

5.  The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.

Authors:  R Homburg; A Ray; P Bhide; A Gudi; A Shah; P Timms; K Grayson
Journal:  Hum Reprod       Date:  2013-02-01       Impact factor: 6.918

Review 6.  Oxidative Stress in Polycystic Ovary Syndrome.

Authors:  Olga Papalou; Victor M Victor; Evanthia Diamanti-Kandarakis
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 7.  Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis.

Authors:  Mora Murri; Manuel Luque-Ramírez; María Insenser; Miriam Ojeda-Ojeda; Hector F Escobar-Morreale
Journal:  Hum Reprod Update       Date:  2013-01-09       Impact factor: 15.610

Review 8.  Anti-Müllerian hormone and polycystic ovary syndrome: a mountain too high?

Authors:  Laura Pellatt; Suman Rice; Helen D Mason
Journal:  Reproduction       Date:  2010-03-05       Impact factor: 3.906

Review 9.  Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome.

Authors:  Francesco Orio; Giovanna Muscogiuri; Cinar Nese; Stefano Palomba; Silvia Savastano; Domenico Tafuri; Giorgio Colarieti; Giovanbattista La Sala; Annamaria Colao; Bulent O Yildiz
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2016-08-12       Impact factor: 2.435

Review 10.  Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome.

Authors:  Helena J Teede; Marie L Misso; Michael F Costello; Anuja Dokras; Joop Laven; Lisa Moran; Terhi Piltonen; Robert J Norman
Journal:  Fertil Steril       Date:  2018-07-19       Impact factor: 7.329

View more
  5 in total

1.  The association between the levels of anti-Müllerian hormone (AMH) and dietary intake in Iranian women.

Authors:  Roya KaboodMehri; Ziba Zahiri Sorouri; Seyedeh Hajar Sharami; Seyedeh Elaheh Bagheri; Shima Yazdipaz; Saeid Doaei
Journal:  Arch Gynecol Obstet       Date:  2021-05-22       Impact factor: 2.344

Review 2.  Metabolic and Molecular Mechanisms of Diet and Physical Exercise in the Management of Polycystic Ovarian Syndrome.

Authors:  Giorgia Scarfò; Simona Daniele; Jonathan Fusi; Marco Gesi; Claudia Martini; Ferdinando Franzoni; Vito Cela; Paolo Giovanni Artini
Journal:  Biomedicines       Date:  2022-06-02

Review 3.  The Treatment with Complementary and Alternative Traditional Chinese Medicine for Menstrual Disorders with Polycystic Ovary Syndrome.

Authors:  Yuehui Zhang; Xiaozhu Guo; Shuting Ma; Haoyue Ma; Hang Li; Yi Wang; Zhen Qin; Xiaoke Wu; Yaguang Han; Yanhua Han
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-17       Impact factor: 2.629

Review 4.  The Effect of Exercise on Cardiometabolic Risk Factors in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Annabelle Breyley-Smith; Aya Mousa; Helena J Teede; Nathan A Johnson; Angelo Sabag
Journal:  Int J Environ Res Public Health       Date:  2022-01-26       Impact factor: 3.390

5.  Effects of high-intensity interval training and strength training on levels of testosterone and physical activity among women with polycystic ovary syndrome.

Authors:  Mubarra Rao; Amna Aamir Khan; Qurat Ul Ain Adnan
Journal:  Obstet Gynecol Sci       Date:  2022-04-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.